Real-World Clinical Outcomes of Multiple Myeloma Patients with High-Risk Cytogenetics Treated with Dararvd, Single Center Experience

被引：0
|
作者：
Aqeel, Sheeba Ba [1 ]
Taneja, Alankrita [1 ]
Groman, Adrienne [1 ]
Parker, Sarah [1 ]
Jatwani, Karan [1 ]
Roy, Arya Mariam [1 ]
Attwood, Kristopher [1 ]
McCarthy, Philip L. [1 ]
Hillengass, Jens [1 ]
机构：
[1] Roswell Park Comprehens Canc Ctr, Buffalo, NY USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-165549
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：13216 / 13217
页数：2
相关论文
共 50 条
  • [1] Real-world Outcomes of Chinese patients with high-risk Multiple Myeloma
    Sui Weiwei
    Deng, Shuhui
    An, Gang
    Xu, Yan
    Hao, Mu
    Mao, Xuehan
    Zou, De-Hui
    Qiu, Lugui
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E222 - E222
  • [2] Real-World Clinical Outcomes in Elderly Chinese Patients with Multiple Myeloma: A Single-Center Experience
    Qian, Xifeng
    Chen, Heng
    Xia, Jun
    Wang, Jing
    Zhou, Xin
    Guo, Hongfeng
    [J]. MEDICAL SCIENCE MONITOR, 2018, 24 : 5887 - 5893
  • [3] The relationship of extramedullary disease and high-risk cytogenetics on real-world outcomes among patients with triple-class exposed multiple myeloma
    Meche, Aster
    Rondeau, Felix
    Vekeman, Francis
    Ren, Jinma
    Schepart, Alexander
    Hlavacek, Patrick
    Farrell, James
    Aydin, Didem
    Nador, Guido
    DiBonaventura, Marco
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S173 - S174
  • [4] The real-world outcomes of multiple myeloma patients treated with daratumumab
    Szabo, Agoston Gyula
    Klausen, Tobias Wirenfeldt
    Levring, Mette Boegh
    Preiss, Birgitte
    Helleberg, Carsten
    Breinholt, Marie Fredslund
    Hermansen, Emil
    Gjerdrum, Lise Mette Rahbek
    Bonlokke, Soren Thorgaard
    Nielsen, Katrine
    Kjeldsen, Eigil
    Iversen, Katrine Fladeland
    Teodorescu, Elena Manuela
    Dokhi, Marveh
    Kurt, Eva
    Strandholdt, Casper
    Andersen, Mette Klarskov
    Vangsted, Annette Juul
    [J]. PLOS ONE, 2021, 16 (10):
  • [5] Real-World Treatment Patterns and Outcomes of Patients with Functional High-Risk (Early Relapse) Multiple Myeloma
    Belli, Andrew J.
    Hansen, Eric
    Kansagra, Ankit
    Dilwali, Keshava
    Wang, Ching-Kun
    [J]. BLOOD, 2020, 136
  • [6] Genetic Abnormalities in a Real-World Cohort of Multiple Myeloma (MM) Patients, and Their Impact on Outcomes: Single-Center Experience
    Vaitekenaite, Vilmante
    Peceliunas, Valdas
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S499 - S500
  • [7] Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma, a Real-World Single Center Experience
    Hultcrantz, Malin
    Derkach, Andriy
    Hassoun, Hani
    Korde, Neha
    Maclachlan, Kylee H.
    Mailankody, Sham
    Patel, Dhwani
    Shah, Urvi A.
    Tan, Carlyn
    Akhlaghi, Theresia
    Hamadeh, Issam S.
    Chung, David J.
    Lahoud, Oscar B.
    Landau, Heather
    Scordo, Michael
    Shah, Gunjan L.
    Giralt, Sergio A.
    Lesokhin, Alexander M.
    Usmani, Saad
    [J]. BLOOD, 2022, 140 : 7246 - 7248
  • [8] Impact of Ultra High-risk Genetics on Real-world Outcomes of Transplant-eligible Multiple Myeloma Patients
    Panopoulou, Aikaterini
    Easdale, Sandra
    Ethell, Mark
    Nicholson, Emma
    Potter, Mike
    Giotas, Asterios
    Woods, Helena
    Thornton, Tracy
    Pawlyn, Charlotte
    Boyd, Kevin D.
    Kaiser, Martin F.
    [J]. HEMASPHERE, 2023, 7 (02): : E831
  • [9] Real-World Outcomes of High-Risk Multiple Myeloma: Retrospective Analysis of Cams&pumc
    Sui, Weiwei
    Deng Shuhui
    An Gang
    Yan Xu
    Yi, Shuhua
    Zou Dehui
    Qiu, Lugui, Sr.
    [J]. BLOOD, 2018, 132
  • [10] Real-world clinical outcomes in patients with multiple myeloma treated with isatuximab after daratumumab treatment
    Taku Kikuchi
    Nobuhiro Tsukada
    Moe Nomura
    Yuki Kasuya
    Yuki Oda
    Kota Sato
    Tomomi Takei
    Mizuki Ogura
    Yu Abe
    Kenshi Suzuki
    Tadao Ishida
    [J]. Annals of Hematology, 2023, 102 : 1477 - 1483
12345